← Evidence map

ArticleOncotarget2017

TFCP2 activates beta-catenin/TCF signaling in the progression of pancreatic cancer.

Dai Yuedi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

16 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29050300